Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin J Meyer

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Degenerative Neurological and Neuromuscular Disease|November 6, 2019
Orphan Drugs In Development For The Treatment Of Friedreich's Ataxia: Focus On OmaveloxoloneShaila D Ghanekar, Wai Wai Miller, Colin J Meyer, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteersNathan S Teuscher, Richard J Kelley, Emily O Dumas, et al.
Redox Biology|December 24, 2013
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney diseaseMohammad A Aminzadeh, Scott A Reisman, Nosratola D Vaziri, et al.
Radiation Research|April 12, 2014
Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitisScott A Reisman, Chun-Yue I Lee, Colin J Meyer, et al.
American Journal of Nephrology|April 22, 2011
Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKDPablo E Pergola, Melissa Krauth, J Warren Huff, et al.
Clinical Science (London, England : 1979)|March 24, 2016
A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathyDevy Deliyanti, Jae Young Lee, Steven Petratos, et al.
Biochemical and Biophysical Research Communications|February 4, 2014
Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2Bin Li, Akram Abdalrahman, Yimu Lai, et al.
BMC Dermatology|July 15, 2015
Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteersScott A Reisman, Angela R Goldsberry, Chun-Yue I Lee, et al.
Molecular Cancer Therapeutics|June 10, 2015
Peloruside A Inhibits Growth of Human Lung and Breast Tumor Xenografts in an Athymic nu/nu Mouse ModelColin J Meyer, Melissa Krauth, Michael J Wick, et al.
Diabetes|January 29, 2011
Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivoYi Tan, Tomonaga Ichikawa, Jinqing Li, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Degenerative Neurological and Neuromuscular Disease|November 6, 2019
Orphan Drugs In Development For The Treatment Of Friedreich's Ataxia: Focus On OmaveloxoloneShaila D Ghanekar, Wai Wai Miller, Colin J Meyer, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteersNathan S Teuscher, Richard J Kelley, Emily O Dumas, et al.
Redox Biology|December 24, 2013
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney diseaseMohammad A Aminzadeh, Scott A Reisman, Nosratola D Vaziri, et al.
Radiation Research|April 12, 2014
Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitisScott A Reisman, Chun-Yue I Lee, Colin J Meyer, et al.
American Journal of Nephrology|April 22, 2011
Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKDPablo E Pergola, Melissa Krauth, J Warren Huff, et al.
Clinical Science (London, England : 1979)|March 24, 2016
A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathyDevy Deliyanti, Jae Young Lee, Steven Petratos, et al.
Biochemical and Biophysical Research Communications|February 4, 2014
Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2Bin Li, Akram Abdalrahman, Yimu Lai, et al.
BMC Dermatology|July 15, 2015
Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteersScott A Reisman, Angela R Goldsberry, Chun-Yue I Lee, et al.
Molecular Cancer Therapeutics|June 10, 2015
Peloruside A Inhibits Growth of Human Lung and Breast Tumor Xenografts in an Athymic nu/nu Mouse ModelColin J Meyer, Melissa Krauth, Michael J Wick, et al.
Diabetes|January 29, 2011
Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivoYi Tan, Tomonaga Ichikawa, Jinqing Li, et al.
Pageof 5